Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1985 Feb;84(2):329–336. doi: 10.1111/j.1476-5381.1985.tb12917.x

Formation of prostanoids during intravascular complement activation in the rabbit.

H Bult, A G Herman, G M Laekeman, M Rampart
PMCID: PMC1987301  PMID: 3884074

Abstract

Plasma concentrations of 6-oxo-prostaglandin F1 alpha (6-oxo-PGF1 alpha) and thromboxane B2 (TXB2) were measured by radioimmunoassay in arterial blood before and after injections of the complement activator, cobra venom factor (CVF). During the control period, the concentration of 6-oxo-PGF1 alpha, which gives the sum of prostacyclin plus 6-oxo-PGF1 alpha, and TXB2 were, respectively, less than 20 pg ml-1 and 70 +/- 15 pg ml-1. Intravenous injections of CVF induced dose-dependent, reversible elevations in the plasma levels of both prostanoids. The time courses for the increases of 6-oxo-PGF1 alpha and TXB2 paralleled the arterial hypotension and thrombocytopenia, suggesting the existence of a causal relationship between these parameters. The results further support our hypothesis that complement-dependent formation of arachidonic acid metabolites contributes to some of the haemodynamic and haematological changes occurring during endotoxin shock.

Full text

PDF
329

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beetens J. R., Van Den Bossche R., Herman A. G. Production of 6-Oxo-PGF1 alpha by aorta rings in the presence of ascorbic acid. Arch Int Pharmacodyn Ther. 1982 Mar;256(1):151–152. [PubMed] [Google Scholar]
  2. Bult H., Beetens J., Herman A. G. Blood levels of 6-oxo-prostaglandin F 1 alpha during endotoxin-induced hypotension in rabbits. Eur J Pharmacol. 1980 Apr 11;63(1):47–56. doi: 10.1016/0014-2999(80)90115-6. [DOI] [PubMed] [Google Scholar]
  3. Bult H., Herman A. G. Influence of endotoxin on arachidonate metabolism in isolated rabbit peritoneum. Biochem Pharmacol. 1983 Sep 1;32(17):2523–2528. doi: 10.1016/0006-2952(83)90013-8. [DOI] [PubMed] [Google Scholar]
  4. Bult H., Herman A. G., Rampart M. Modification of endotoxin-induced haemodynamic and haematological changes in the rabbit by methylprednisolone, F(ab')2 fragments and rosmarinic acid. Br J Pharmacol. 1985 Feb;84(2):317–327. doi: 10.1111/j.1476-5381.1985.tb12916.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Christ-Hazelhof E., Nugteren D. H. Prostacyclin is not a circulating hormone. Prostaglandins. 1981 Nov;22(5):739–746. doi: 10.1016/0090-6980(81)90213-6. [DOI] [PubMed] [Google Scholar]
  6. Coker S. J., Hughes B., Parratt J. R., Rodger I. W., Zeitlin I. J. The release of prostanoids during the acute pulmonary response to E. coli endotoxin in anaesthetized cats. Br J Pharmacol. 1983 Mar;78(3):561–570. doi: 10.1111/j.1476-5381.1983.tb08816.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Flynn J. T. Effect of lidocaine on hepatic prostanoid production in vitro following 2,4-dinitrophenol administration. Adv Shock Res. 1983;10:149–159. [PubMed] [Google Scholar]
  8. GILBERT V. E., BRAUDE A. I. Reduction of serum complement in rabbits after injection of endotoxin. J Exp Med. 1962 Oct 1;116:477–490. doi: 10.1084/jem.116.4.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Galanos C., Rietschel E. T., Lüderitz O., Westphal O. Interaction of lipopolysaccharides and lipid A with complement. Eur J Biochem. 1971 Mar 1;19(1):143–152. doi: 10.1111/j.1432-1033.1971.tb01298.x. [DOI] [PubMed] [Google Scholar]
  10. Haslam R. J., McClenaghan M. D. Measurement of circulating prostacyclin. Nature. 1981 Jul 23;292(5821):364–366. doi: 10.1038/292364a0. [DOI] [PubMed] [Google Scholar]
  11. Jacob H. S. Complement-induced vascular leukostasis. Its role in tissue injury. Arch Pathol Lab Med. 1980 Dec;104(12):617–620. [PubMed] [Google Scholar]
  12. Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
  13. Moncada S., Vane J. R. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin. Pharmacol Rev. 1978 Sep;30(3):293–331. [PubMed] [Google Scholar]
  14. O'Flaherty J. T., Craddock P. R., Jacob H. S. Mechanism of anti-complementary activity of corticosteroids in vivo: possible relevance in endotoxin shock. Proc Soc Exp Biol Med. 1977 Feb;154(2):206–209. doi: 10.3181/00379727-154-39638. [DOI] [PubMed] [Google Scholar]
  15. Rampart M., Bult H., Herman A. G. Activated complement and anaphylatoxins increase the in vitro production of prostacyclin by rabbit aorta endothelium. Naunyn Schmiedebergs Arch Pharmacol. 1983 Mar;322(2):158–165. doi: 10.1007/BF00512390. [DOI] [PubMed] [Google Scholar]
  16. Rampart M., Bult H., Herman A. G. Contribution of complement activation to the rise in blood levels of 6-oxo-prostaglandin F1 alpha during endotoxin-induced hypotension in rabbits. Eur J Pharmacol. 1982 Apr 8;79(1-2):91–99. doi: 10.1016/0014-2999(82)90578-7. [DOI] [PubMed] [Google Scholar]
  17. Rampart M., Van Hove C., Bult H., Claeys M., Herman A. G. Mechanism of complement-induced stimulation of prostacyclin production by isolated rabbit peritoneum. Prostaglandins. 1983 Feb;25(2):245–261. doi: 10.1016/0090-6980(83)90108-9. [DOI] [PubMed] [Google Scholar]
  18. Schrauwen E., Vandeplassche G., Laekeman G., Houvenaghel A. Endotoxin shock in the pig: release of prostaglandins and beneficial effects of flurbiprofen. Arch Int Pharmacodyn Ther. 1983 Apr;262(2):332–334. [PubMed] [Google Scholar]
  19. Ulevitch R. J., Cochrane C. G. Complement-dependent hemodynamic and hematologic changes in the rabbit. Inflammation. 1977 Sep;2(3):199–216. doi: 10.1007/BF00917596. [DOI] [PubMed] [Google Scholar]
  20. Ulevitch R. J., Cochrane C. G., Henson P. M., Morrison D. C., Doe W. F. Mediation systems in bacterial lipopolysaccharide-induced hypotension and disseminated intravascular coagulation. I. The role of complement. J Exp Med. 1975 Dec 1;142(6):1570–1590. doi: 10.1084/jem.142.6.1570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Waldmann H., Lachmann P. J. The failure to show a necessary role for C3 in the in vitro antibody response. Eur J Immunol. 1975 Mar;5(3):185–193. doi: 10.1002/eji.1830050307. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES